Mithieux G, Ajzannay A, Minassian C
INSERM U. 197, Faculté de Médecine Alexis Carrel, Lyon, France.
J Biochem. 1995 Apr;117(4):908-14. doi: 10.1093/oxfordjournals.jbchem.a124795.
Three recent reports have suggested that rat liver microsomal glucose-6 phosphatase (Glc6Pase) should be a 62-64 kDa polypeptide. In this work, we examine the possibility that the 62-64 kDa could represent a functional dimeric form of the 36.5 kDa glucose-6 phosphate (Glc6P)-phosphohydrolase, previously identified [Countaway et al. (1988) J. Biol. Chem. 263, 2672-2678]. From 32P-labeling experiments with 32P-Glc6P and analysis of 32P-labeled protein by SDS-PAGE and autoradiography, we show that three different rat liver microsomal polypeptides, the apparent molecular masses of which are 62, 54, and 37 kDa, may be specifically labeled with 32P-Glc6P. We demonstrate that the 62 kDa polypeptide is a microsome-bound form of cytosolic phosphoglucomutase, by combining labeling competition experiments and enzymatic assay. It should likely not account for a putative dimeric form of Glc6P-phosphohydrolase. The 37 kDa polypeptide fulfills the criteria of Glc6P-phosphohydrolase. We have not obtained any definitive evidence for its assembly as a dimer under functioning conditions. The 32P-Glc6P-labeling characteristics of the 54 kDa polypeptide are those expected for a protein displaying affinity in the millimolar range of concentration and a high binding capacity for Glc6P. They are consistent with those of a 54 kDa microsomal polypeptide, previously suggested to be involved in Glc6Pase activity.
最近的三篇报道表明,大鼠肝脏微粒体葡萄糖-6磷酸酶(Glc6Pase)应为一种62 - 64 kDa的多肽。在本研究中,我们探讨了62 - 64 kDa的多肽是否可能代表先前已鉴定的36.5 kDa葡萄糖-6磷酸(Glc6P)-磷酸水解酶的功能性二聚体形式[Countaway等人(1988年)《生物化学杂志》263, 2672 - 2678]。通过用32P-Glc6P进行32P标记实验,并通过SDS-PAGE和放射自显影分析32P标记的蛋白质,我们发现大鼠肝脏微粒体中三种不同的多肽,其表观分子量分别为62、54和37 kDa,可能会被32P-Glc6P特异性标记。通过结合标记竞争实验和酶活性测定,我们证明62 kDa的多肽是胞质磷酸葡萄糖变位酶的微粒体结合形式。它可能不是Glc6P-磷酸水解酶假定的二聚体形式。37 kDa的多肽符合Glc6P-磷酸水解酶的标准。我们尚未获得其在功能条件下组装成二聚体的确切证据。54 kDa多肽的32P-Glc6P标记特征符合在毫摩尔浓度范围内显示亲和力且对Glc6P具有高结合能力的蛋白质的预期特征。它们与先前认为参与Glc6Pase活性的54 kDa微粒体多肽的特征一致。